- ¥3bn
- ¥3bn
- ¥5bn
- 64
- 36
- 38
- 42
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.67 | ||
Price to Tang. Book | 2.26 | ||
Price to Free Cashflow | 17.76 | ||
Price to Sales | 0.46 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -4.35% | ||
Return on Equity | -10.12% | ||
Operating Margin | -1.56% |
Financial Summary
Year End 31st May | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | ¥m | 2,917.87 | 2,904.6 | 3,745.76 | 4,500.85 | 5,252.06 | n/a | n/a | 18.62% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -14.99 | +109.54 | +72.99 | -29.42 | -38.21 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Medical Net, Inc. is a Japan-based company mainly engaged in media platform business, medical institution management support business and medical business-to-business (BtoB) business. The Company operates through three business segments. Media Platform segment operates a dedicated portal that provides specific information about the body, health, beauty and parenting. Medical Institution Management Support segment provides search engine marketing (SEM) services that includes search engine optimization (SEO) services and listing advertising (search-linked advertising) operation agency services, corporate Website creation and maintenance services, as well as agency sales services. It also operates dental clinics and sells equipment, instruments and medicines to dental clinics. Medical BtoB segment operates a BtoB portal site that includes dental workers.
Directors
- Akira Hayakawa CHM (60)
- Dai Hirakawa PRE (48)
- Ryusuke Hayakawa EDR (43)
- Takahisa Ishii EDR
- Tsuyoshi Uchida EDR (38)
- Yuji Hirakawa DRC (43)
- Eiji Tsuchiya IND (56)
- Last Annual
- May 31st, 2024
- Last Interim
- February 28th, 2025
- Incorporated
- June 1st, 2001
- Public Since
- December 21st, 2010
- No. of Shareholders
- 12,767
- No. of Employees
- 274
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange
- Shares in Issue
- 8,794,170

- Address
- 3F, Takara Bldg., 1-34-14, Hatagaya, SHIBUYA-KU, 151-0072
- Web
- https://www.medical-net.com/
- Phone
- +81 357905261
- Auditors
- Moore Shisei & Co
Upcoming Events for 3645
Similar to 3645
Advantage Risk Management Co
Tokyo Stock Exchange
AHC
Tokyo Stock Exchange
Amvis Holdings
Tokyo Stock Exchange
Artra
Tokyo Stock Exchange
As Partners Co
Tokyo Stock Exchange
FAQ
As of Today at 21:58 UTC, shares in Medical Net are trading at ¥314. This share price information is delayed by 15 minutes.
Shares in Medical Net last closed at ¥314 and the price had moved by -15.36% over the past 365 days. In terms of relative price strength the Medical Net share price has underperformed the Nikkei 225 Index by -10.81% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Medical Net dividend yield is 0.96% based on the trailing twelve month period.
Last year, Medical Net paid a total dividend of ¥3, and it currently has a trailing dividend yield of 0.96%.Looking ahead, shares in Medical Net are due to go ex-dividend on 2025-05-29 and the next dividend pay date is 2025-08-01.
Medical Net are due to go ex-dividend on 2025-05-29 and the next dividend pay date is 2025-08-01. The historic dividend yield on Medical Net shares is currently 0.96%.
To buy shares in Medical Net you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥314, shares in Medical Net had a market capitalisation of ¥3bn.
Here are the trading details for Medical Net:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 3645
Based on an overall assessment of its quality, value and momentum Medical Net is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medical Net. Over the past six months, its share price has outperformed the Nikkei 225 Index by +8.47%.
As of the last closing price of ¥314, shares in Medical Net were trading -3.8% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medical Net PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥314.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medical Net's management team is headed by:
- Akira Hayakawa - CHM
- Dai Hirakawa - PRE
- Ryusuke Hayakawa - EDR
- Takahisa Ishii - EDR
- Tsuyoshi Uchida - EDR
- Yuji Hirakawa - DRC
- Eiji Tsuchiya - IND